Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI)

NCT02184234 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim